A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Conditions

• Hematopoietic and Lymphatic System Neoplasm
• Hematopoietic and Lymphoid System Neoplasm
• Malignant Solid Neoplasm

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Best Practice — OTHER
  Receive enhanced usual care
• Educational Intervention — OTHER
  Receive ASCENT guide
• Questionnaire Administration — OTHER
  Ancillary studies
• Electronic Health Record Review — OTHER
  Ancillary studies
• Health Telemonitoring — PROCEDURE
  Attend video or phone calls with a CHW and/or PCM
• Cancer Pain Management — BEHAVIORAL
  Receive personalized pain management plan

Study Details

This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. All cancer survivors stand to benefit from electronic health record innovations, as they can experience profound pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially helpful and can be customized to address patient needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in cancer survivors.

Key Dates

Start date

Feb 7, 2024

Status verified

Apr 2026

Primary completion

Jan 31, 2027

Completion

Aug 31, 2027

Study Design

Enrollment

660 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Active Comparator: Arm I (enhanced usual care)
  Patients receive enhanced usual care, which includes access to the educational and pain self-management materials developed for the ASCENT trial (the ASCENT guide).
• Experimental: Arm II (ASCENT intervention)
  Patients receive the ASCENT guide and attend 3 video or phone calls over 30 minutes each with their CHW and/or PCM. During the first call, patients discuss barriers to receiving help for their pain with their CHW. During the second call, patients work with their PCM to develop an action plan for addressing their pain using the different techniques and interventions detailed in the ASCENT guide. During the third and final call, patients meet with both their CHW and PCM to discuss specialist recommendations for their pain management plan. After the final visit, patients will be contacted by the CHW or PCM every other week to monitor their progress and may also be contacted as-needed based on the their reported pain intensity, symptoms, or reported barriers.

Primary Outcome Measure

Change in Pain Score [ Time Frame: Baseline, 3 months, 6 months ]

Central Contacts

• Clinical Trials Referral Office
  507-293-1043
  [email protected]
• Josiah Lulf
  507-538-7991
  [email protected]

Locations (3)

Find similar trials in Scottsdale, AZ

Related Studies

• Project: Every Child for Younger Patients With Cancer
  Recruiting · Children's Oncology Group · Birmingham, Alabama
• Collection and Storage of Tissue and Blood Samples From Patients With Cancer
  Recruiting · National Cancer Institute LAO · Birmingham, Alabama
• Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
  Recruiting · Mayo Clinic · Scottsdale, Arizona
• Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
  PHASE3 · Recruiting · Mayo Clinic · Scottsdale, Arizona